Logos Global Management »

Moonlake Immunot shares owned by Logos Global Management

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $33M 750k 43.97
2023-12-31 $9.1M 150k 60.39

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
T. Rowe Price Associates
Citadel Advisors
Holocene Advisors
Goldman Sachs Group
Federated Investors
Westfield Capital Management Company
Marshall Wace
Alliancebernstein
Logos Global Management
Fred Alger Management
Balyasny Asset Management
Nuveen Asset Management
BlackRock

View all funds holding Moonlake Immunot